Kernal creates mRNA therapies to cure severe diseases including cancer. Our mRNA therapies instruct specific cells on how to make their own drugs. With roots at MIT, Harvard and Big Pharma, our team previously built a successful Biotech company and has deep expertise in mRNA space.
External link for Kernal Biologics
700 Main St
Cambridge, Massachusetts 02139, US
Kernal Biologics reposted this
I'm excited to be giving a talk on "Characterization of T-cell targeted CAR #mRNA LNPs" at the 9th CAR-TCR Summit in Boston this September! You can join me at 1.40PM on Day 1 (Wednesday 18th). Learn more here: https://lnkd.in/eKcr9jXa #CARTCR #mRNA CAR-TCR Summit Series Kernal Biologics
Kernal Biologics reposted this
Manfred Kraus, Kernal Biologics’ Sr. VP of R&D will be presenting at the mRNA-Based Therapeutics Summit tomorrow! #mRNASummit #mRNATherapeutics
I’m looking forward to presenting at the 4th mRNA-Based Therapeutics Summit tomorrow July 30th. See my session details in the event program here: https://lnkd.in/gNnuhm4H #mRNASummit #WorldRNA #mRNAVaccines #mRNATherapeutics
Kernal Biologics reposted this
𝐀𝐈 𝐱 𝐁𝐢𝐨 𝐒𝐮𝐦𝐦𝐢𝐭: Kernal Biologics co-founder Yusuf Erkul describes designing mRNA therapies that are selectively delivered to, and translated by, specific cells in the body. He explains the four components that go into getting mRNA to the right location in the body and to be translated in the right cells, and how technology is allowing the company to do this work today. Full video: https://lnkd.in/gK7MVivp BiotechTV is brought to you by: Mispro | Breakthrough Properties | HSBC Innovation Banking | Theragent Inc | NYSE | Allucent
Kernal Biologics reposted this
I had the pleasure to sit down with Brad Loncar of BiotechTV at the AI x Bio Summit in New York Stock Exchange today. We discussed our cutting-edge work on next generation mRNA LNP therapeutics at Kernal Biologics. Many thanks to the organizers Pablo Lubroth and Amee Kapadia and hosts Decoding Bio Hummingbird Ventures Cantos and NYSE for putting together another great summit this year! Also a big shoutout to the sponsors Bunsen, McKinsey & Company, HSBC, Orrick, Herrington & Sutcliffe LLP and Amazon Web Services (AWS)!
𝐀𝐈 𝐱 𝐁𝐢𝐨 𝐒𝐮𝐦𝐦𝐢𝐭: Kernal Biologics co-founder Yusuf Erkul describes designing mRNA therapies that are selectively delivered to, and translated by, specific cells in the body. He explains the four components that go into getting mRNA to the right location in the body and to be translated in the right cells, and how technology is allowing the company to do this work today. Full video: https://lnkd.in/gK7MVivp BiotechTV is brought to you by: Mispro | Breakthrough Properties | HSBC Innovation Banking | Theragent Inc | NYSE | Allucent
Kernal Biologics reposted this
𝐀𝐈 𝐱 𝐁𝐢𝐨 𝐒𝐮𝐦𝐦𝐢𝐭: Kernal Biologics co-founder Yusuf Erkul describes designing mRNA therapies that are selectively delivered to, and translated by, specific cells in the body. He explains the four components that go into getting mRNA to the right location in the body and to be translated in the right cells, and how technology is allowing the company to do this work today. Full video: https://lnkd.in/gK7MVivp BiotechTV is brought to you by: Mispro | Breakthrough Properties | HSBC Innovation Banking | Theragent Inc | NYSE | Allucent
Cafer Ozdemir, PhD, Co-founder & Director of Convergence Science at Kernal Bio, gave a great presentation today at the 11th International mRNA Health Conference in Berlin, Germany. The title of his talk was "Engineering Synthetic mRNAs That Are Selectively Translated In Cancer Cells."